Table 2.
Effect of partially informative vs. non-informative prior
| Prior | Relative risk of uterine quiescence | Difference in time to delivery |
|---|---|---|
| Partially informative prior using data from phase 2 dose-ranging study | 1.53 (95% CrI 0.98, 2.48) | 8.2 (95% CrI 2.7, 13.74) |
| Non-informative prior (phase 2a proof of concept study only) | 1.54 (95% CrI 0.94, 2.63) | 7.3 (95% CrI 1.0, 13.5) |
CrI, credible interval.